Login
Existing Account

Please login first to complete purchase/ quotation request, view custom order reports, or create favorites list.

Customer ID:
Password:
Stay Logged In


Forgot your Customer ID or Password?
New Account

Don't have an account with us yet? Please set up an account to place order or obtain customer services.

Assay Kits  >  Alzheimer's and Parkinson's Disease  >>  SensoLyte® Anti-Mouse/ Rat β-Amyloid (1-42) Quantitative ELISA *Colorimetric*

Product Name SensoLyte® Anti - Mouse/ Rat β - Amyloid (1 - 42) Quantitative ELISA *Colorimetric*
Size 1 kit
Catalog # AS-55554
US$ $435
Description

This SensoLyte® high-sensitivity (2pg/ml) beta-Amyloid (1-42) Quantitative ELISA Kit (Mouse/Rat) provides a convenient and quantitative assay for determining mouse/rat beta-Amyloid (1-42) (Aβ42) amount in cell and tissue lysate as well as in body fluids. Compared to other mouse/rat anti-Aβ42 ELISA kits on the market, it takes less time to run this assay. HRP conjugated detection antibody in this kit is added simultaneously with the samples and standards during the assay. This eliminates extra incubation and washing steps and makes this kit a one-step procedure for Aβ42 quantification.

Alzheimer's Disease (AD) is the most common neurodegenerative disorder in elderly people. It has been demonstrated that AD has biological causes and is characterized by the presence of senile plaques and neurofibrillary tangles mainly in cerebral cortex and hippocampus brain regions.1-5 Beta-Amyloid (1-40) (Aβ40) and beta-Amyloid (1-42) (Aβ42) are the main components of the above plaques; however, other forms of beta-Amyloid peptides are also present. Both peptides are cleaved from the Amyloid Precursor Protein (APP) by β-secretase and γ-secretase enzymes.2,3,5 Many studies suggest that Aβ42 or/and Aβ43 are required to initiate formation of amyloid plaques and neurofibrills that leads to the neurodegeneration,1-5 while Aβ40 is less neurotoxic.

Detailed Information Datasheet
Material Safety Data Sheets (MSDS)
Poster
References 1. Levites Y. et al., J Clin Invest 116(1): 193-201: 2006 2. Broersen K. et al., Alzheimer’s Res Therapy 2: 1-14, 2010 3. Zhang Yun-Wu, et al., Mol Brain 4: 1-13: 2011 4. Koechling T., et al., Intl J Alzheimer’s Dis, 2010 5. Bobba A., et al., Intl J Alzheimer’s Dis, 2010 6. Bermejo-Pareja F., et al., BMC Neurol, 2010
Product Citations Zhang, J. et al. (2014). Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's Disease. J Neurosci 34, 14919. doi: 10.1523/JNEUROSCI.1165-14.2014.
     
  < Back